February 25, 2025 - 11:18

Rocket Companies, a prominent player in the fintech sector based in Detroit, is set to have its CEO, Varun Krishna, present at the upcoming Morgan Stanley Technology, Media & Telecom Conference. This event is a significant gathering for industry leaders, providing a platform for discussions on the latest trends and innovations in technology and finance.
During his presentation, Krishna is expected to share insights into the company's strategic vision and its role in shaping the future of the mortgage and real estate industries. As Rocket Companies continues to expand its offerings and enhance customer experiences, Krishna's insights will likely highlight the company's commitment to leveraging technology for streamlined financial solutions.
The Morgan Stanley conference is renowned for attracting top executives and investors, making it an ideal venue for Rocket Companies to showcase its advancements and connect with potential partners. Stakeholders and industry watchers will be keen to hear about the company's future initiatives and how it plans to navigate the evolving landscape of fintech.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...